‘Levelling-up’: The emerging role of education technology
Al Kingsley, CEO at NetSupport, discusses the potential role of education technology in "levelling up" - especially for vulnerable communities.
True disruption in education: An opportune moment for lasting change?
Christel Wolthoorn, Managing Director of LovedBy Design, examines how the education sector dealt with COVID disruption and the work that remains.
Study shows fourth booster dose increases antibodies fivefold
In Israel, healthcare professionals and those over 60 are now being encouraged to take the fourth booster dose - which appears to significantly increase waning third dose antibodies.
Study finds young COVID patients have increased oxidative stress
According to new data, even young COVID patients have increased oxidative stress - a factor connected to ageing, diabetes and HIV.
Shark antibody-like proteins could neutralise COVID-19 viruses
Antibody-like proteins from the immune systems of sharks could help to prepare for future coronaviruses, according to new research.
Convidecia vaccine 57.5% effective against symptomatic COVID
Phase Three trial shows Convidecia vaccine 57.5% effective against symptomatic COVID, while 91.7% effective against severe COVID.
Study identifies factors in blood linked to severe COVID
Unique “indicators” in the blood of patients with severe and fatal COVID could create simple diagnostic tests - to help doctors identify who could become critically ill.
European Commission approves Novavax COVID vaccine for use
The Commission gave a conditional marketing authorisation (CMA) to the Novavax COVID vaccine, with 100 million doses expected in early 2022.
Scientists say AstraZeneca protection decreases after three months
According to data from two million people in Scotland and 42 million people in Brazil, AstraZeneca vaccine protection drops significantly three months after double-dosing.
Study says prior infection gives 19% protection against Omicron
COVID infection previously created 85% protection against Delta - now, scientists say that this protection falls to 19% against Omicron.
What are the side effects of the Moderna booster vaccine?
Here, we explain side effects of the Moderna booster vaccine - while taking a look at the Omicron variant.
Vaccinating rough sleepers with £28 million government funding
The government is aiming to vaccinate those who are homeless and sleeping rough with the Protect and Vaccinate scheme, relocating people on the street to safe accommodation over winter.
Human & animal health, food security & biosecurity
Curtis R Youngs from Iowa State University probes the relationship between human and animal health in light of the COVID-19 pandemic, including comment on the food system & biosecurity programmes.
Caring for those who care for us
Claudia Marinetti, Director of Mental Health Europe, calls for action to curb the prevalence of mental distress amongst frontline health workers.
10 years of the Social Value Act
As 2022 marks 10 years since the Social Value Act came into force, Guy Battle, CEO, Social Value Portal takes stock of where we are, and how things look for the year to come.
